MEN 10208

• Description :

  MEN 10208 is a neurokinin A antagonist prepared by solid phase synthesis. The Fmoc strategy has more advantages than the Boc strategy in its preparation, and can obtain products with higher yield and purity.

• CAS Number :

  [129781-07-3]

• UNSPSC :

  12352209

• Target :

  Neurokinin Receptor

• Type :

  Peptides

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Others

• Assay Protocol :

  https://www.medchemexpress.com/men-10208.html

• Smiles :

  N=C(N)NCCC[C@@H](C(N)=O)NC([C@@H](CC1=CNC2=CC=CC=C12)NC([C@H](NC([C@H](C(C)C)NC([C@H](NC([C@@H](NC([C@H](CC(O)=O)NC([C@@H](N)[C@H](O)C)=O)=O)CC3=CC=C(C=C3)O)=O)CC4=CNC5=CC=CC=C45)=O)=O)CC6=CNC7=CC=CC=C67)=O)=O

• Molecular Formula :

  C61H75N15O12

• Molecular Weight :

  1210.34

• References & Citations :

  [1]Solid-phase synthesis of neurokinin A antagonists. Comparison of the Boc and Fmoc methods

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Peptides

• Clinical Information :

  No Development Reported